Skip to content
HowShorted

How shorted was DICE Therapeutics, Inc.? DICE

DICE Therapeutics, Inc. left the US market in 2023. This page is a frozen archive of its reported short interest, ending 31 Jul 2023. The ticker DICE no longer refers to this company and may since have been reassigned.
9.13%
of shares outstanding reported short ยท settlement date 31 Jul 2023
vs previous report
โˆ’1.10
5 reports (~10 weeks)
โˆ’7.66
days to cover
5.20
Aggregate net short position time series for DICE Therapeutics, Inc.

Markers along the chart's base: โ–ฒ results announced (an 8-K reporting results was filed) โ–ฒ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for DICE Therapeutics, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
11 May 202318.44% 28 Apr 202316.79% 15 May 2023โˆ’1.65
15 Mar 202312.69% 28 Feb 202317.05% 31 Mar 2023+4.36
9 Nov 20229.15% 31 Oct 20229.12% 15 Nov 2022โˆ’0.03
13 Oct 202213.35% 30 Sep 202210.72% 14 Oct 2022โˆ’2.63
11 Aug 202215.41% 29 Jul 202214.82% 15 Aug 2022โˆ’0.59
12 May 20226.78% 29 Apr 20228.34% 13 May 2022+1.56
21 Mar 20226.68% 15 Mar 20226.04% 31 Mar 2022โˆ’0.64

Fails to deliver

The SEC's fails-to-deliver figure for DICE: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Latest balance
453
14 Sep 2026
Highest in window
606
11 Sep 2026
Days with a balance
3
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for DICE Therapeutics, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 606 shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Share on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
31 Jul 20239.13%โˆ’1.10
14 Jul 202310.23%+1.22
30 Jun 20239.01%โˆ’8.00
15 Jun 202317.01%+0.61
31 May 202316.40%โˆ’0.39
15 May 202316.79%โˆ’1.65
28 Apr 202318.44%+0.63
14 Apr 202317.81%+0.76
31 Mar 202317.05%+2.69
15 Mar 202314.36%+1.67
28 Feb 202312.69%+0.64
15 Feb 202312.05%+0.60
31 Jan 202311.45%+0.38
13 Jan 202311.07%+0.37
30 Dec 202210.70%+1.48
15 Dec 20229.22%โˆ’0.01
30 Nov 20229.23%+0.11
15 Nov 20229.12%โˆ’0.03
31 Oct 20229.15%โˆ’1.57
14 Oct 202210.72%โˆ’2.63
30 Sep 202213.35%+0.45
15 Sep 202212.90%โˆ’0.75
31 Aug 202213.65%โˆ’1.17
15 Aug 202214.82%โˆ’0.59
29 Jul 202215.41%+0.03
15 Jul 202215.38%+0.36
30 Jun 202215.02%+2.62
15 Jun 202212.40%+2.95
31 May 20229.45%+1.11
13 May 20228.34%+1.56
29 Apr 20226.78%+0.54
14 Apr 20226.24%+0.20
31 Mar 20226.04%โˆ’0.64
15 Mar 20226.68%+0.99
28 Feb 20225.69%+0.68
15 Feb 20225.01%โˆ’0.29
31 Jan 20225.30%โˆ’0.73
14 Jan 20226.03%โˆ’0.43
31 Dec 20216.46%+1.52
15 Dec 20214.94%+1.34
30 Nov 20213.60%+0.75
15 Nov 20212.85%โ€“

Newest first. Scroll inside the table for earlier dates, back to 15 Nov 2021.

Frequently asked questions

How shorted was DICE Therapeutics, Inc.?
DICE Therapeutics, Inc. left the US market in 2023. Its final reported figure was 9.13% of shares outstanding for settlement date 31 Jul 2023, per FINRA's consolidated short interest report; this page preserves its full history.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this DICE's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is DICE's days to cover?
5.20 days for settlement date 31 Jul 2023: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.